<DOC>
	<DOCNO>NCT00874393</DOCNO>
	<brief_summary>This trial test feasibility enrol 60 extremely preterm infant randomize , double-blinded study blood pressure management within 12 month . Eligible infant receive infusion drug ( dopamine dextrose placebo ) syringe drug ( hydrocortisone normal saline placebo ) . Enrolled infant randomize receive one follow drug pair : - dopamine hydrocortisone - dopamine normal saline - dextrose hydrocortisone - dextrose normal saline . In addition intervention , NRN conduct 6-month time-limited prospective observational study infant bear NRN center 23 26 week gestational age . All clinical decision make baby discretion attend neonatologist/infant care team accord standard practice institution . Data blood pressure management first 24 postnatal hour collect infant .</brief_summary>
	<brief_title>Early Blood Pressure Management Extremely Premature Infants</brief_title>
	<detailed_description>Since extremely preterm infant critically ill immediate postnatal period , establish `` normal '' blood pressure ( BP ) value difficult . This lack data make decide institute therapy hypotension ( low BP ) challenging , lead considerable variability BP management neonatal intensive care unit ( NICUs ) . Despite lack data safety efficacy , many 64 % extremely preterm infant receive inotropes ( e.g. , dopamine ) , 12.4 % low birthweight infant receive hydrocortisone perceive hypotension . Since untreated low BP therapy provide low BP may harmful , decision whether treat important issue . To date , prospective randomize , control trial BP management population perform . This trial test feasibility enrol 60 extremely preterm infant randomize , double-blinded study blood pressure management within 12 month . It enroll 60 infant 23 0/7 26 6/7 week gestational age bear 6 participate NICHD Neonatal Research Network sit . Eligible infant receive study infusion drug ( dopamine dextrose placebo ) study syringe drug ( hydrocortisone normal saline placebo ) . Infants randomize receive one follow drug pair : ( 1 ) dopamine hydrocortisone ; ( 2 ) dopamine placebo ( normal saline solution ) ; ( 3 ) placebo ( dextrose ) hydrocortisone ; ( 4 ) placebo ( dextrose ) placebo ( normal saline ) . ( NOTE : dopamine normally mixed dextrose hydrocortisone mixed saline solution administer , two different placebo use trial . ) The information gather provide framework design potential large , multi-centered , randomize control trial . NOTE : The NICHD Neonatal Research Network receive FDA exemption IND regulation trial . In addition interventional trial , NRN conduct 6-month time-limited prospective observational study infant bear NRN center 23 26 week gestational age . All clinical decision make baby discretion attend neonatologist/infant care team accord standard practice institution . Data blood pressure management first 24 postnatal hour collect infant . Based slow rate recruitment , time-limited observational study hypotension ELBW infants add current study .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Dopamine Agents</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<criteria>Inborn infant 23 0/7 26 6/7 week estimate gestational age Umbilical arterial catheter place study entry &lt; = 24 hour age Terminally ill infant Infants receive ( prior enrollment ) : &gt; 20 ml/kg fluid bolus , indomethacin , ibuprofen Infants major congenital anomaly</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Hours</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>NICHD Neonatal Research Network</keyword>
	<keyword>Very Low Birth Weight ( VLBW )</keyword>
	<keyword>Extremely Low Birth Weight ( ELBW )</keyword>
	<keyword>Prematurity</keyword>
	<keyword>Blood Pressure Management</keyword>
	<keyword>Dopamine</keyword>
	<keyword>Hydrocortisone</keyword>
</DOC>